Clearside Biomedical (CLSD) Revenue & Revenue Breakdown
Clearside Biomedical Revenue Highlights
Latest Revenue (Y)
$8.23M
Latest Revenue (Q)
$1.04M
Main Segment (Y)
License
Clearside Biomedical Revenue by Period
Clearside Biomedical Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $8.23M | 519.89% |
2022-12-31 | $1.33M | -95.51% |
2021-12-31 | $29.57M | 274.65% |
2020-12-31 | $7.89M | 263.28% |
2019-12-31 | $2.17M | 7143.33% |
2018-12-31 | $30.00K | -91.30% |
2017-12-31 | $345.00K | -33.65% |
2016-12-31 | $520.00K | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | - |
Clearside Biomedical Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $1.04M | 1053.33% |
2024-06-30 | $90.00K | -60.87% |
2024-03-31 | $230.00K | -96.38% |
2023-12-31 | $6.34M | 638.65% |
2023-09-30 | $859.00K | -15.62% |
2023-06-30 | $1.02M | 25350.00% |
2023-03-31 | $4.00K | -98.79% |
2022-12-31 | $330.00K | 24.06% |
2022-09-30 | $266.00K | -30.73% |
2022-06-30 | $384.00K | 10.66% |
2022-03-31 | $347.00K | -98.65% |
2021-12-31 | $25.69M | 735.62% |
2021-09-30 | $3.07M | 294.10% |
2021-06-30 | $780.00K | 2194.12% |
2021-03-31 | $34.00K | 209.09% |
2020-12-31 | $11.00K | -99.68% |
2020-09-30 | $3.43M | 869.49% |
2020-06-30 | $354.00K | -91.36% |
2020-03-31 | $4.10M | 110.97% |
2019-12-31 | $1.94M | 1277.30% |
2019-09-30 | $141.00K | 213.33% |
2019-06-30 | $45.00K | - |
2019-03-31 | $45.00K | 50.00% |
2018-12-31 | $30.00K | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $55.00K | -64.52% |
2017-09-30 | $155.00K | 19.23% |
2017-06-30 | $130.00K | 2500.00% |
2017-03-31 | $5.00K | - |
2016-12-31 | $5.00K | - |
2016-09-30 | $5.00K | - |
2016-06-30 | $5.00K | -99.01% |
2016-03-31 | $505.00K | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | - |
Clearside Biomedical Revenue Breakdown
Clearside Biomedical Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
License | $8.20M | $1.30M | - | - | - |
Other Agreement | - | - | $13.00K | $200.00K | - |
License And Service | - | - | - | - | $105.00K |
Latest
Quarterly Revenue by Product
Product/Service | Jun 20 | Sep 19 | Jun 19 | Mar 19 |
---|---|---|---|---|
License And Service | $200.00K | $141.00K | $45.00K | $45.00K |
Latest
Clearside Biomedical Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Jun 20 | Sep 19 | Jun 19 | Mar 19 |
---|---|---|---|---|
License And Service | $200.00K | $141.00K | $45.00K | $45.00K |
Latest
Clearside Biomedical Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
OCUL | Ocular Therapeutix | $58.44M | $14.71M |
CLSD | Clearside Biomedical | $8.23M | $1.04M |
KRON | Kronos Bio | $6.29M | $2.37M |
GBIO | Generation Bio | $5.90M | $4.09M |
INBX | Inhibrx Biosciences | $1.80M | - |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
EYEN | Eyenovia | $3.79K | $1.63K |
DSGN | Design Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
GRCL | Gracell Bio | - | - |
INZY | Inozyme Pharma | - | - |
NXTC | NextCure | - | - |
GRPH | LENZ Therapeutics | - | - |
ERAS | Erasca | - | - |
DRTS | Alpha Tau Medical | - | - |
EPIX | ESSA Pharma | - | - |
SNSE | Sensei Biotherapeutics | - | - |
MACK | Merrimack Pharmaceuticals | - | - |
ORIC | ORIC Pharmaceuticals | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
TNYA | Tenaya Therapeutics | - | - |
NUVB | Nuvation Bio | - | $727.00K |